115
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

A Compact Synthesis and Biological Evaluation of Biginilli Products of 1,3-Bis(3-Chlorophenyl)-2-Thioxodihydropyrimidine-4,6(1H,5H)-Dione

, , , &
Pages 131-140 | Received 13 May 2021, Accepted 15 Nov 2021, Published online: 28 Nov 2021

References

  • B. B. Touré, and D. G. Hall, “Natural Product Synthesis Using Multicomponent Reaction Strategies,” Chemical Reviews 109, no. 9 (2009): 4439–86.
  • Giovanna Bosica, Fiona Cachia, Riccardo De Nittis, and Nicole Mariotti, “Efficent One-Pot Synthesis of 3,4-Dihydropyrimidine-2(1H)-Ones via a Three-Component Biginelli Reaction,” Molecules 26, no. 12 (2021): 3753.
  • Vijay Dabholkar, and Dilip Ravi, “Synthesis of Biginelli Products of Thiobarbituricacids and Their Antimicrobial Activity,” Journal of the Serbian Chemical Society 75, no. 8 (2010): 1033–40.
  • M. Sontakke, A. A. Jichkar, M. G. Dhonde, C. S. Bhaskar, and B. N. Berad, “C-SBond-Forming Reactions of Barbiturylbromide with Isothiocarbamides in Aqueous Media,” Synthetic Communications 44, no. 3 (2014): 340–5.
  • Heba S. A. El-Zahabi, Maha M. A. Khalifa, Yomna M. H. Gado, Amel M. Farrag, Mahmoud M. Elaasser, Nesreen A. Safwat, Reham R. AbdelRaouf, and Reem K. Arafa, “New Thiobarbituric Acid Scaffold-Based Small Molecules: Synthesis, Cytotoxicity, 2D-QSAR, Pharmacophore Modelling and In-Silico ADME Screening,” European Journal of Pharmaceutical Sciences: official Journal of the European Federation for Pharmaceutical Sciences 130, (2019): 124–36.
  • D. Pareeka, M. Chaudharya, P. K. Pareekb, R. Kantc, K. G. Ojhab, S. M. U. Iraqiaand, and A. Pareek, “Synthesis of Some Biologically Important 2-Thiobarbituric Acidderivatives Incorporating Benzothiazole Moiety,” Der Pharmacia Letter 2, no. 4 (2010): 274–83.
  • M. S. Masoud, A. S. Hassan, N. M. Desouky, H. M. Kamel, and A. S. E. Kholany, “Thermal and Potentiometric Studies for Complexes of Zr and Hf with Some Barbituric Acid Derivatives,” IOP Conference Series: Materials Science and Engineering 975, (2021): 012015.
  • G. Rajitha, V. Ravibabu, G. Ramesh, and B. Rajitha, “Synthesis and Antimicrobialactivity of Novel Imidazo[1,2-a]Pyridinopyrimidine-2,4,6(1H,3H,5H)-Triones Andhioxopyrimidine-4,6(1H,5H)Diones,” Research on Chemical Intermediates 42, no. 3 (2016): 1989–98.
  • R. Thakur, R. Mohan, and M. Kidwai, “Ecofriendly Synthesis of Novel Antifungal(Thio)Barbituric Acid Derivatives,” Acta Chimica Slovenica, no. 52 (2005): 88–92.
  • C. M. U. Khan, M. Aslam, S. A. Shahzad, Z. A. Khan, N. A. Khan, M. Ali, S. Naz, J. Rahman, and U. Farooq, “Design and Synthesis of Thiobarbituric Acid Analogues as Potent Urease Inhibitors,” Journal of Molecular Structure 1231, (2021): 129959.
  • M. Ali, A. Barakat, A. E. Faham, H. H. A. Rasheed, K. Dahlous, A. M. A. Majid, A. Sharma, S. Yousuf, M. Sanam, Z. U. Haq, et al. “Synthesis and Characterisation of Thiobarbituric Acid Enamine Derivatives, and Evaluation of Their α-Glucosidase Inhibitory and Anti-Glycation Activity,” Journal of Enzyme Inhibition and Medicinal Chemistry 35, no. 1 (2020): 692–701.
  • G. Kapoor, D. Pathak, P. Bhutani, and R. Kant, “Thiazolidinone as Apharmacologically Active Molecule,” Journal of Chemical and Pharmaceutical Research 52, no. 8 (2016): 151–68.
  • A. R. Trivedi, V. R. Bhuva, B. H. Dholariya, D. K. Dodiya, V. B. Kataria, and V. H. Shah, “Novel Dihydropyrimidines as a Potential New Class of Antitubercular Agents,” Bioorganic & Medicinal Chemistry Letters 20, no. 20 (2010): 6100–2.
  • H. R. Arias, E. A. Mc Cardy, M. J. Gallagher, and M. P. Blanton, “Interaction ofBarbiturate Analogs with the Torpedo Californica Nicotinic Acetylcholine ReceptorIon Channel,” Molecular Pharmacology 60 (2001): 497–506.
  • A. Agarwal, S. Lata, K. Saxena, V. Srivastava, and A. Kumar, “Synthesis and Anticonvulsant Activity of Some Potential Thiazolidinonyl 2-oxo/thiobarbituric Acids,” European Journal of Medicinal Chemistry 41, no. 10 (2006): 1223–9.
  • P. Singh, M. Kaur, and P. Verma, “Design, Synthesis and Anticancer Activities of Hybrids of Indole and Barbituric Acids-Identification of Highly Promising Leads,” Bioorganic & Medicinal Chemistry Letters 19, no. 11 (2009): 3054–8.
  • A. D. Brewer, J. A. Minatelli, J. Plowman, K. D. Paull, and V. Narayanan, “5-(Nphenylcarboxamido)-2-Thiobarbituric Acid (NSC 336628), a Novel Potential Antitumoragent,” Biochemical Pharmacology 34, no. 11 (1985): 2047–50.
  • S. Y. Lee, B. S. Webb, A. K. Sharma, and J. R. Connor, “Characterization of a Novel Barbituric Acid and Two Thiobarbituric Acid Compounds for Lung Cancer Treatment,” Anticancer Research 40, no. 11 (2020): 6039–49. [PMC][10.21873/anticanres.14625] [33109542]
  • B. S. Jursic, and D. M. Neumann, “Reductive C-Alkylation of Barbituric Acidderivatives with Carbonyl Compounds in the Presence of Platinum and Palladiumcatalysts,” Tetrahedron Letters 42, no. 25 (2001): 4103–7.
  • A. F. Afonso, O. R. Pereira, and S. M. Cardoso, “Health-Promoting Effects of Thymus Phenolic-Rich Extracts: Antioxidant, anti-Inflammatory and Antitumoral Properties,” Antioxidants 9, no. 9 (2020): 814.
  • J. Wang, C. Medina, M. W. Radomski, and J. F. Gilmer, “N-Substituted Homopiperazine Barbiturates as Gelatinase Inhibitors,” Bioorganic & Medicinal Chemistry 19, no. 16 (2011): 4985–99.
  • S. K. Gautam, S. K. Gupta, and B. Yogi, “Synthesis and Anticonvulsant Activity of New 5-((1-(2-(4-Substituted Phenacyl Bromide)-2-Oxoethyl)-2-Phenyl-1H-Indol-3yl) Methylene) Pyrimidine-2, 4, 6(1H, 3H, 5H)-Trione Derivatives,” Research Journal of Pharmacy and Technology 14 (2021): 2681–5.
  • S. Rajamaki, A. Innitzer, C. Falciani, C. Tintori, F. Christ, M. Witvrouw, Z. Debyser, S. Massa, and M. Botta, “Exploration of Novel Thiobarbituric Acid-, Rhodanine- and Thiohydantoin-Based HIV-1 Integrase Inhibitors,” Bioorganic & Medicinal Chemistry Letters 19, no. 13 (2009): 3615–8.
  • V. I. Balas, I. I. Verginadis, G. D. Geromichalos, N. Kourkoumelis, L. Male, M. B. Hursthouse, K. H. Repana, E. Yiannaki, K. Charalabopoulos, T. Bakas, et al. “Synthesis, Structural Characterization and Biological Studies of the Triphenyltin(IV) Complex with 2-Thiobarbituric Acid,” European Journal of Medicinal Chemistry 46, no. 7 (2011): 2835–44.
  • M. A. Abdullah, M. Ali, Z. Zinab, and T. Z. Mohammed, “Synthesis of Some New Aryl Thiobarbituric Acid Derivatives as Antibacterial and Antifungal Agents,” Indian Journal of Forensic Medicine & Toxicology 13, no. 2 (2019): 286–90.
  • Z. Chen, D. Cai, D. Mou, Q. Yan, Y. Sun, W. Pan, Y. Wan, H. Song, and W. Yi, “Design, Synthesis and Biological Evaluation of Hydroxy- or Methoxy-Substituted 5-Benzylidene(Thio) Barbiturates as Novel Tyrosinase Inhibitors,” Bioorganic & Medicinal Chemistry 22, no. 13 (2014): 3279–84.
  • Q. Yan, R. Cao, W. Yi, L. Yu, Z. Chen, L. Ma, and H. Song, “Synthesis and Evaluation of 5-Benzylidene(thio)barbiturate-Beta-D-Glycosides as Mushroom Tyrosinase Inhibitors,” Bioorganic & Medicinal Chemistry Letters 19, no. 15 (2009): 4055–8.
  • M. H. M. A. Azim, M. A. Aziz, S. M. Mounier, A. F. E. Farargy, and W. S. Shehab, “Ecofriendly Synthesis of Pyrano[2,3‐d]Pyrimidine Derivatives and Related Heterocycles with anti‐Inflammatory Activities,” Archiv der Pharmazie 353 (2020): 1–13.
  • N. R. Penthala, P. R. Ponugoti, V. Kasam, and P. A. Crooks, “5-((1-Aroyl-1H-indol-3-yl)methylene)-2-Thioxodihydropyrimidine-4,6(1H,5H)-Diones as Potential Anticancer Agents with Anti-Inflammatory Properties,” Bioorganic & Medicinal Chemistry Letters 23, no. 5 (2013): 1442–6.
  • H. M. Faidallah, and K. A. Khan, “Synthesis and Biological Evaluation of Newbarbituric and Thiobarbituric Acid Fluoro Analogs of Benzenesulfonamidesasantidiabetic and Antibacterial Agents,” Journal of Fluorine Chemistry 142, (2012): 96–104.
  • P. P. Mohire, R. B. Patil, D. R. Chandam, S. J. Jadhav, A. A. Patravale, D. R. Kumbhar, J. S. Ghosh, and M. B. Deshmukh, “Low Transition Temperature Mixturesprompted One-Pot Synthesis of 5, 10 Dihydropyrimido[4,5-b]Quinoline-2,4(1H,3H)-Dione Derivatives,” Research on Chemical Intermediates 43, no. 12 (2017): 7013–28.
  • H. G. Abdulwahab, M. F. Harras, N. G. Menofy, A. M. Hegab, B. M. Essa, A. A. A. Selim, T. M. Sakr, and H. S. A. E. Zahabi, “Novel Thiobarbiturates as Potent Urease Inhibitors with Potential Antibacterial Activity: Design, Synthesis, Radiolabeling and Biodistribution Study,” Bioorganic & Medicinal Chemistry 28, no. 23 (2020): 115759.
  • N. N. Pesyan, D. Soleimani, and N. H. Jazani, “New Tetrazolic Azo Dyes Linked to(Thio)Barbiturate and Electron-Rich Aromatics as Potential Antimicrobial Agents,” Turkish Journal of CHEMISTRY 39, (2015): 998–1011.
  • Q. Yan, R. Cao, W. Yi, Z. Chen, H. Wen, L. Ma, and H. Song, “Inhibitory Effects of 5-Benzylidene Barbiturate Derivatives on Mushroom Tyrosinase and Their Antibacterial Activities,” European Journal of Medicinal Chemistry 44, no. 10 (2009): 4235–43.
  • V. Singh, S. Haque, S. Khare, A. K. Tiwari, D. Katiyar, B. Banerjee, K. Kumari, and C. K. M. Tripathi, “Isolation and Purification of Antibacterial Compound from Streptomyces levis Collected from Soil Sample of North India,” PloS One 13, no. 7 (2018): e0200500.
  • R. K. Sharma, V. Singh, N. Tiwari, R. J. Butcher, and D. Katiyar, “Synthesis, Antimicrobial and Chitinase Inhibitory Activities of 3-Amidocoumarins,” Bioorganic Chemistry 98, (2020): 103700.
  • J. T. Bojarski, J. L. Mokrosz, H. J. Barton’and, and M. H. Paluchowska, “RecentProgress in Barbituric Acid Chemistry,” Advances in Heterocyclic Chemistry 38 (1985): 229–97.
  • N. Sharma, V. Singh, A. K. Pandey, B. N. Mishra, M. Kulsoom, N. Dasgupta, S. Khan, H. A. El-Enshasy, and S. Haque, “Preparation and Evaluation of the ZnO NP–Ampicillin/Sulbactam Nanoantibiotic: optimization of Formulation Variables Using RSM Coupled GA Method and Antibacterial Activities,” Biomolecules 9, no. 12 (2019): 764.
  • Priyanka V., Singh Ekta, and D. Katiyar, “Synthesis, Antimicrobial, Cytotoxic and E. coli DNA Gyrase Inhibitory Activities of Coumarinyl Amino Alcohols,” Bioorganic Chemistry 71 (2017): 120–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.